D Pharm Ltd  

(Public, TLV:DPRM)   Watch this stock  
Find more results for JOSHUA D. SHAPIRO
9.90
Jul 28 - Close
TLV data delayed by 20 mins - Disclaimer
Currency in ILA unless noted
Range     -
52 week 0.09 - 0.16
Open     -
Vol / Avg. 0.00/145,034.00
Mkt cap 21.25M*
P/E     -
Div/yield     -
EPS -0.09*
Shares 204.28M
Beta     -
Inst. own     -
*ILS
Jul 10, 2015
D Pharm Ltd Annual Shareholders Meeting (Estimated)
  

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -52.20% -57.93%
Return on average equity -61.01% -68.96%
Employees 12 -
CDP Score - -

Address

Kiryat Weizmann Science Park, Bldg. 7 P.O. Box 2313
REHOVOT, 76123
Israel
+972-8-9385100 (Phone)
+972-8-9300795 (Fax)

Website links

Description

D-Pharm Ltd. is an Israel-based drug-development company. The Company is focused on developing drugs for the treatment of central nervous system (CNS) conditions. Its area of interest is in developing medicine for degenerative and age-related disorders. The Company’s product portfolio includes three clinical Phase II drug-candidates: THR-18 for thrombolysis, to restore blood flow to the brain, heart or lungs, which completed clinical Phase I and Phase II study in acute stroke patients receiving tPA; DP-VPA for the treatment of epilepsy, migraine and manic depression, which has completed a Phase II study in patients with complex partial epilepsy, and DP-b99, which contains calcium, zinc and copper ions and is used for the protection of cells under stress in acute pancreatitis. The Company’s two technology platforms Membrane Activated Chelator and Regulated Activation of Prodrug use lipid moieties conjugated onto actives such as metal ion chelators or drugs for site specific activation.

Officers and directors

Aharon Schwartz Executive Chairman of the Board
Age: 71
Alexander Kozak Ph.D. President, Chief Executive Officer, Founder
Ofra Yamin Vice President of Finance and Human Resources
Age: 50
Gilad Rosenberg M.D. Vice President, Clinical Development
Age: 48
Yaron Meyer General Counsel, Secretary
Age: 34
Israel Shapiro Head of Chemistry, Analytics and Formulation
Age: 75
Sigal Gefen External Director
Age: 48
Ofer Gonen Director
Age: 42
Tamar Kfir Director
Age: 46
Joshua Levine Director
Age: 56